← Open Payments lookup

JORDAN FROSCH: Open Payments

NPI 1215666581 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$982 in 46 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $370 · 2025 $982

Food & beverage: $982
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$172
Eisai Inc.4$125
Takeda Pharmaceuticals U.S.A., Inc.4$103
Mallinckrodt Hospital Products Inc.3$83
Madrigal Pharmaceuticals3$69
Merck Sharp & Dohme LLC2$68
Intercept Pharmaceuticals, Inc.3$57
Genentech USA, Inc.2$49
Mirum Pharmaceuticals, Inc.2$39
Alexion Pharmaceuticals, Inc.2$34

Products named: XIFAXAN, Lenvima, LIVTENCITY, TERLIVAZ, REZDIFFRA, OCALIVA, Tecentriq, Livmarli.

Industry payments across TX — which companies pay providers there.